UnitedHealth Group Incorporated (NYSE:UNH) Holdings Raised by Principal Street Partners LLC

Principal Street Partners LLC lifted its position in UnitedHealth Group Incorporated (NYSE:UNH) by 90.0% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 2,917 shares of the healthcare conglomerate’s stock after acquiring an additional 1,382 shares during the period. Principal Street Partners LLC’s holdings in UnitedHealth Group were worth $1,706,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Delta Financial Group Inc. grew its holdings in shares of UnitedHealth Group by 1.0% during the third quarter. Delta Financial Group Inc. now owns 1,650 shares of the healthcare conglomerate’s stock valued at $965,000 after buying an additional 17 shares in the last quarter. Signature Resources Capital Management LLC boosted its holdings in shares of UnitedHealth Group by 40.0% during the second quarter. Signature Resources Capital Management LLC now owns 63 shares of the healthcare conglomerate’s stock worth $32,000 after purchasing an additional 18 shares during the period. Saxony Capital Management LLC increased its stake in UnitedHealth Group by 3.5% in the 2nd quarter. Saxony Capital Management LLC now owns 530 shares of the healthcare conglomerate’s stock valued at $270,000 after buying an additional 18 shares during the period. GoalVest Advisory LLC boosted its stake in shares of UnitedHealth Group by 0.6% during the 2nd quarter. GoalVest Advisory LLC now owns 3,124 shares of the healthcare conglomerate’s stock valued at $1,591,000 after buying an additional 18 shares during the period. Finally, Fiduciary Group LLC raised its holdings in shares of UnitedHealth Group by 0.5% during the second quarter. Fiduciary Group LLC now owns 3,695 shares of the healthcare conglomerate’s stock worth $1,882,000 after acquiring an additional 18 shares in the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

UnitedHealth Group Stock Performance

NYSE UNH opened at $605.83 on Tuesday. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.91 and a quick ratio of 0.91. The company’s fifty day moving average is $582.96 and its two-hundred day moving average is $553.99. UnitedHealth Group Incorporated has a 52-week low of $436.38 and a 52-week high of $630.73. The firm has a market capitalization of $557.54 billion, a price-to-earnings ratio of 39.45, a P/E/G ratio of 1.73 and a beta of 0.58.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share for the quarter, topping the consensus estimate of $7.00 by $0.15. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. The company had revenue of $100.82 billion for the quarter, compared to analyst estimates of $99.14 billion. During the same quarter last year, the firm earned $6.56 EPS. UnitedHealth Group’s revenue for the quarter was up 9.2% compared to the same quarter last year. Equities research analysts forecast that UnitedHealth Group Incorporated will post 27.6 EPS for the current year.

UnitedHealth Group Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Tuesday, December 17th. Stockholders of record on Monday, December 9th will be issued a $2.10 dividend. The ex-dividend date is Monday, December 9th. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.39%. UnitedHealth Group’s payout ratio is presently 54.72%.

Analysts Set New Price Targets

Several research analysts have weighed in on UNH shares. Royal Bank of Canada dropped their target price on UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating on the stock in a research report on Wednesday, October 16th. Bank of America cut their price objective on shares of UnitedHealth Group from $675.00 to $650.00 and set a “buy” rating on the stock in a research report on Wednesday, October 16th. Truist Financial restated a “buy” rating and set a $625.00 price target (down previously from $640.00) on shares of UnitedHealth Group in a research note on Wednesday, October 16th. Morgan Stanley decreased their price objective on shares of UnitedHealth Group from $615.00 to $610.00 and set an “overweight” rating for the company in a report on Wednesday, October 16th. Finally, Hsbc Global Res cut UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a research report on Thursday, October 17th. Four research analysts have rated the stock with a hold rating, seventeen have given a buy rating and two have issued a strong buy rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $615.53.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.